Stimvia
PrivateLast Round
Series A
Sep 18, 2023
Company Overview
Stimvia operates in Healthcare & Life Sciences and is based in Ostrava. Its latest recorded funding round was a VC Round in June 2021.
Stimvia is a medical technology company that develops non-invasive neuromodulation systems for the treatment of chronic diseases such as overactive bladder and Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stimvia Comparables
Compare Stimvia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EBT Medical | 90% | |
| Stimuli Technology | 82% | |
| Avation Medical | 78% |
For institutional investors. Book with your work email.
Stimvia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 18, 2023 | ||||
| VC Round | Jun 1, 2021 | ||||
| Angel | Jul 7, 2014 |
For institutional investors. Book with your work email.
Stimvia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Purple Ventures | VC Round |
| Soulmates Ventures | VC Round |
| Climate KIC | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2021
$4.6M round led by Purple Ventures and Soulmates Ventures.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- promotesOct 1, 2026
Stimvia plans to promote founder Lukas Doskocil to Founder and Chief Product Officer, where he leads product strategy, technology development, and the advancement of its next-generation neuromodulation platform.
- hiresOct 1, 2026
On Oct 1st '26, Stimvia appoints Russ Mably as Chief Executive Officer to lead its next phase of international growth and expand access to its personalised neuromodulation platform.
For institutional investors. Book with your work email.
Stimvia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Stimvia's valuation, stock price, and market status.
Is Stimvia a public or private company?
Stimvia is a private company.
What is the current stock price of Stimvia?
Stimvia is a private company, so its shares have no public market price. Caplight tracks Stimvia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Stimvia worth (valuation)?
Valuation information for Stimvia is not publicly available.
Can I buy Stimvia stock?
Stimvia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Stimvia's last funding round?
Stimvia's most recent funding round was Series A on September 18, 2023.
Who are the main investors in Stimvia?
Key investors in Stimvia include Purple Ventures, Soulmates Ventures, Climate KIC.
Will Stimvia IPO soon?
No public IPO plans have been announced for Stimvia.
How can I track Stimvia secondary market activity?
Caplight tracks bids, offers, and trades in Stimvia's shares on secondary markets.